| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Department of Ophthalmology, University of Essen, Germany; 2 Department of Ophthalmology, St. Franziskus Hospital, Muenster, Germany; and the 3 Department of Ophthalmology, Ocular Surface and Tear Center, Bascom Palmer Eye Institute, University of Miami School of Medicine, Florida.
PURPOSE. Stromal herpes simplex virus keratitis (HSK) is an immune-mediated disease. Previous studies have indicated that T cells, neutrophils, and macrophages contribute to the tissue damage in HSK. It has been shown that human amniotic membrane promotes epithelial wound healing and has diverse anti-inflammatory effects. In this study, the effect of amniotic membrane transplantation (AMT) on corneal wound healing and on inflammation in mice with necrotizing HSK was examined.
METHODS. BALB/c mice were corneally infected with 105 plaque-forming units (PFU) of HSV-1 (KOS strain). In 16 mice that exhibited severe ulcerating HSK, the cornea was covered with a preserved human amniotic membrane as a patch. Corneas in 16 infected mice remained uncovered and served as a control. On days 2 and 7 after surgery, the amniotic membrane was removed (eight mice in each group), the HSV-1–infected cornea was evaluated clinically, and the eye was enucleated. Tissue sections were analyzed histologically for epithelialization and cellular infiltration and immunohistochemically with anti-CD3 mAb to T cells, anti-CD11b mAb to both macrophages and neutrophils, or anti-F4/80 mAb to macrophages.
RESULTS. Profound regression of corneal inflammation and rapid closure of epithelial defects were observed clinically within 2 days in the amniotic membrane-covered eyes, whereas HSV-1 keratitis and ulceration progressed in all mice in the control group (P < 0.001). Histologically, corneal edema and inflammatory infiltration, and immunohistochemically the number of CD3+, CD11b+, and F4/80+ cells in the cornea were markedly decreased at 2 and 7 days after amniotic membrane application, compared with the uncovered control corneas (P < 0.001).
CONCLUSIONS. AMT promotes rapid epithelialization and reduces stromal inflammation and ulceration in HSV-1 keratitis. AMT in mice with HSV necrotizing stromal keratitis appears to be a useful model for investigating the effect and the action mechanism of human amniotic membrane.
This article has been cited by other articles:
|
|
 |
|
  D. Bauer, S. Wasmuth, M. Hennig, H. Baehler, K.-P. Steuhl, and A. Heiligenhaus Amniotic Membrane Transplantation Induces Apoptosis in T Lymphocytes in Murine Corneas with Experimental Herpetic Stromal Keratitis Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3188 - 3198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. He, W. Li, S.-Y. Chen, S. Zhang, Y.-T. Chen, Y. Hayashida, Y.-T. Zhu, and S. C. G. Tseng Suppression of Activation and Induction of Apoptosis in RAW264.7 Cells by Amniotic Membrane Extract Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4468 - 4475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kheirkhah, D. A. Johnson, D. R. Paranjpe, V.K. Raju, V. Casas, and S. C. G. Tseng Temporary Sutureless Amniotic Membrane Patch for Acute Alkaline Burns Arch Ophthalmol, August 1, 2008; 126(8): 1059 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. S. Barequet, Z. Habot-Wilner, N. Keller, G. Smollan, H. Ziv, M. Belkin, and M. Rosner Effect of Amniotic Membrane Transplantation on the Healing of Bacterial Keratitis Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 163 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Heiligenhaus, H. F. Li, Y. Yang, S. Wasmuth, K. P. Steuhl, and D. Bauer Transplantation of Amniotic Membrane in Murine Herpes Stromal Keratitis Modulates Matrix Metalloproteinases in the Cornea Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4079 - 4085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-K. Yeh, W.-L. Chen, W. Li, E. M. Espana, J. Ouyang, T. Kawakita, W. W.-Y. Kao, S. C. G. Tseng, and C.-Y. Liu Soluble Lumican Glycoprotein Purified from Human Amniotic Membrane Promotes Corneal Epithelial Wound Healing Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 479 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wasmuth, D. Bauer, Y. Yang, K.-P. Steuhl, and A. Heiligenhaus Topical Treatment with Antisense Oligonucleotides Targeting Tumor Necrosis Factor-{alpha} in Herpetic Stromal Keratitis Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5228 - 5234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Heiligenhaus, H Li, E E Hernandez Galindo, J M Koch, K-P Steuhl, and D Meller Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation Br J Ophthalmol, October 1, 2003; 87(10): 1215 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-E. Ti, D. Anderson, A. Touhami, C. Kim, and S. C. G. Tseng Factors Affecting Outcome Following Transplantation of Ex vivo Expanded Limbal Epithelium on Amniotic Membrane for Total Limbal Deficiency in Rabbits Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2584 - 2592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C G TSENG Amniotic membrane transplantation for persistent corneal epithelial defect Br J Ophthalmol, December 1, 2001; 85(12): 1400 - 1401. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
